Related Experiment Videos

New insights into the neuropathogenesis of molybdenum cofactor deficiency

Michael S Salman1, Cameron Ackerley, Christof Senger

  • 1Department of Neurology, Hospital for Sick Children, Toronto, ON, Canada.

Abstract

Insights

Molybdenum cofactor deficiency (MOCOD) leads to excess sulfur and magnesium in brain neurons. This accumulation may cause excitotoxic injury, contributing to neurodegeneration in this rare disorder.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Molybdenum cofactor deficiency (MOCOD) is a rare, progressive neurodegenerative disorder resulting from sulphite oxidase enzyme deficiency.
  • Neuropathological findings in MOCOD include severe neuronal loss, reactive astrogliosis, and spongiosis, suggesting a toxic brain insult.
  • The underlying mechanisms driving these neuropathological changes in MOCOD remain largely unknown.

Observation:

  • Autopsy of a male infant with MOCOD revealed neuropathological examination including cytochemical staining for disulphide bonds and elemental analysis of cortical cells.
  • Neurons in the MOCOD brain exhibited cytoplasmic staining with shikata and orcein, indicating alterations in disulphide bonds.
  • Scanning electron microscopy with energy dispersive X-ray spectrometry identified excess sulphur and magnesium accumulation within the neurons of the affected infant.

Findings:

  • Abnormal accumulation of sulphur and magnesium was detected in the neurons of an infant with Molybdenum cofactor deficiency (MOCOD).
  • Cytochemical staining revealed abnormal disulphide bond patterns in the neurons of the MOCOD patient.
  • Elemental analysis confirmed significantly higher concentrations of sulphur and magnesium in the neurons compared to age-matched controls.

Implications:

  • The study postulates that sulphur-containing compounds, resulting from MOCOD, may induce excitotoxic neuronal injury in the presence of excess magnesium.
  • These findings suggest a novel mechanism contributing to the neurodegenerative pathology observed in Molybdenum cofactor deficiency.
  • Further research into the role of sulphur and magnesium metabolism in MOCOD could lead to new therapeutic strategies.

Related Concept Videos